Immune checkpoint inhibitors: Promising but still inaccessible treatment option for patients with head-and-neck cancer in India-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitors: Promising but still inaccessible treatment option for patients with head-and-neck cancer in India

Published:2022-07 Issue:3 Volume:5 Page:587-588
ISSN:2590-3233
Container-title:Cancer Research, Statistics, and Treatment
language:en
Short-container-title:

Author:

Dhumal Sachin¹,Patil Vijay²,Noronha Vanita²,Prabhash Kumar²

Affiliation:

1. Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Kharghar, Homi Bhabha National Institute, Mumbai, Maharashtra, India

2. Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, Maharashtra, India

Publisher

Medknow

Reference12 articles.

1. Incidence and pattern of distribution of cancer in India:A secondary data analysis from six population-based cancer registries;Shetty;Cancer Res Stat Treat,2020

2. Role of early palliative care in advanced head-and-neck cancers patients;Satija;Indian J Palliat Care,2019

3. Impact of demographic factors on delayed presentation of oral cancers:A questionnaire-based cross-sectional study from a rural cancer center;Singla;Cancer Res Stat Treat,2022

4. Demography and pattern of care of patients with head-and-neck carcinoma:Experience from a tertiary care center in North India;Roy;Cancer Res Stat Treat,2020

5. Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck:2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression;Ferris;Oral Oncol,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP